Skip to Main Content

Paper Details

Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy.
Mayo Clin Proc
9
2020

Datasets

Release 1.2